Evidence map›Paper›PMID 39052702›Full record

ArticleThe Journal of infectious diseases2024

The Clinical and Economic Burden of Antibiotic Use in Pediatric Patients With Varicella Infection: A Retrospective Cohort Analysis of Real-World Data in England.

Stephanie A Kujawski, Victoria Banks, Caroline S Casey, Simon B Drysdale, Amisha Patel, Olivia Massey, Tim Holbrook, Manjiri Pawaskar

Abstract read
In one paragraph

Article in The Journal of infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Stephanie A KujawskiCenter for Observational and Real-world Evidence, Merck & Co., Inc., Rahway, New Jersey, USA.ORCID 0000-0001-7915-8553
Victoria BanksReal-world Evidence, Adelphi Real World, Bollington, United Kingdom.
Caroline S CaseyReal-world Evidence, Adelphi Real World, Bollington, United Kingdom.
Simon B DrysdaleDepartment of Paediatrics, St George's University Hospitals NHS Foundation Trust, London, United Kingdom.
Amisha PatelReal-world Evidence, Adelphi Real World, Bollington, United Kingdom.
Olivia MasseyReal-world Evidence, Adelphi Real World, Bollington, United Kingdom.
Tim HolbrookReal-world Evidence, Adelphi Real World, Bollington, United Kingdom.
Manjiri PawaskarCenter for Observational and Real-world Evidence, Merck & Co., Inc., Rahway, New Jersey, USA.

Funding

Merck & CoMerck Sharp & Dohme
6 · The paper itself

Abstract

backgroundVaricella is a highly infectious disease, particularly affecting children, that can lead to complications requiring antibiotics or hospitalization. Antibiotic use for varicella management is poorly documented. This study assessed antibiotic use for varicella and its complications in a pediatric population in England.

methodsData were drawn from medical records in the Clinical Practice Research Datalink and Hospital Episode Statistics data sets. The study included patients <18 years old with varicella diagnosed during 2014-2018 and 3-month follow-up available. We determined varicella-related complications, medication use, healthcare resource utilization, and costs from diagnosis until 3 months after diagnosis.

resultsWe identified 114 578 children with a primary varicella diagnosis. Of these, 7.7% (n = 8814) had a varicella-related complication, the most common being ear, nose, and throat related (37.1% [n = 3271]). In all, 25.9% (n = 29 706 of 114 578) were prescribed antibiotics. A higher proportion of patients with complications than without complications were prescribed antibiotics (64.3% [n = 5668 of 8814] vs 22.7% [n = 24 038 of 105 764]). Mean annualized varicella-related costs were £2 231 481 for the study cohort. Overall, antibiotic prescriptions cost approximately £262 007.

conclusionsThis study highlights high antibiotic use and healthcare resource utilization associated with varicella management, particularly in patients with complications. A national varicella vaccination program in England may reduce varicella burden and related complications, medication use, and costs.

Indexed as

Anti-Bacterial AgentsChickenpoxAdolescentChildChild, PreschoolCost of IllnessEnglandFemaleHealth Care CostsHospitalizationHumansInfantInfant, NewbornMaleRetrospective StudiesAnti-Bacterial AgentsantibioticscostsEnglandpediatricvaricella

Identifiers

PMID39052702
PMCPMC11272041

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.